Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer
- Resource Type
- Authors
- Thomas Kümler; Merete Vaage-Nilsen; Kirsten Vistisen; Dorte Nielsen; Anne Dyhl-Polk; Jon Appel; Cecilia Margareta Lund; Morten Schou
- Source
- Acta Oncologica. 59:475-483
- Subject
- Adult
Male
musculoskeletal diseases
Oncology
medicine.medical_specialty
Drug-Related Side Effects and Adverse Reactions
Colorectal cancer
Denmark
Myocardial Ischemia
030218 nuclear medicine & medical imaging
Capecitabine
Young Adult
03 medical and health sciences
0302 clinical medicine
Breast cancer
Risk Factors
Internal medicine
Antineoplastic Combined Chemotherapy Protocols
medicine
Humans
Radiology, Nuclear Medicine and imaging
Young adult
Aged
Retrospective Studies
Aged, 80 and over
Cardiotoxicity
business.industry
Incidence
Incidence (epidemiology)
Retrospective cohort study
Hematology
General Medicine
Middle Aged
medicine.disease
Fluorouracil
030220 oncology & carcinogenesis
Female
Colorectal Neoplasms
business
medicine.drug
- Language
- ISSN
- 1651-226X
0284-186X
Background: Fluoropyrimidines are mainstay chemotherapeutics in the treatment of gastrointestinal cancers and are also used to treat breast cancer and head and neck cancers. However, 5-flourouracil...